Curavit, 1nHealth Aim to Accelerate DCT Patient Recruitment Times


Partnership uses a digital approach featuring conversational AI and remote patient monitoring to help speed up enrollment

Curavit Clinical Research, a virtual contract research organization (VCRO), is partnering with 1nHealth, a patient recruitment provider, in an effort to speed up patient recruitment digitally for decentralized clinical trials (DCTs). 1nHealth integrates with Curavit’s branded DCT platform, speeding trial enrollment, and improving retention. The parties’ first collaboration is for Lark Health’s trial of an investigational digital therapeutic (DTx) for chronic cardiovascular disease.

Lark’s Heart Health program is designed to help patients manage cardiovascular disease (CVD) risk factors and reduce the rate of future cardiovascular diseases or events. The smartphone-based program uses conversational AI, connected devices, and remote patient monitoring to activate and engage patients by addressing CVD risk factors such as diet, exercise, and tobacco use.

“We are excited to partner with Curavit to improve patient recruitment by simplifying participant identification and enrollment through digital channels,” says Dan Brenner, founder and CEO of 1nHealth. “As a technology-first company, we are closely aligned with Curavit’s mission to bring trials to patients in the cloud. Our partnership will drive faster enrollments and more inclusive trial participation.”

Patient recruitment has been an ongoing challenge when it comes to clinical trials. Globally, according to the National Center for Biotechnology Information (NCBI), 90% of all clinical trials are delayed due to insufficient patient enrollment. As a result, timelines are typically extended to nearly double their original duration to meet desired enrollment levels.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.